(Q56990581)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19822073%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

0 references

1 reference

title

Tumor necrosis factor-alpha antagonists: differential clinical effects by different biotechnological molecules (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19822073%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19822073%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

author name string

F Licastro

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19822073%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

M Chiappelli

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19822073%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

M Ianni

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19822073%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

language of work or name

English

0 references

publication date

1 July 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19822073%20AND%20SRC:MED&resulttype=core&format=json

International Journal of Immunopathology and Pharmacology

9 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19822073%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

volume

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19822073%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19822073%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

page(s)

567-572

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19822073%20AND%20SRC:MED&resulttype=core&format=json

The impact of infliximab treatment on quality of life in patients with inflammatory rheumatic diseases

9 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1177%2F039463200902200302

Biological agents for rheumatoid arthritis: targeting both physical function and structural damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200902200302

Drug insight: different mechanisms of action of tumor necrosis factor antagonists-passive-aggressive behavior?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200902200302

TNFalpha blockade in human diseases: mechanisms and future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200902200302

Etanercept (Enbrel): update on therapeutic use

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200902200302

Infliximab induces potent anti-inflammatory responses by outside-to-inside signals through transmembrane TNF-alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200902200302

Does route of administration affect the outcome of TNF antagonist therapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200902200302

Anti-TNF-alpha therapies: they are all the same (aren't they?).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200902200302

Long-term infliximab treatment in rheumatoid arthritis: subsequent outcome of initial responders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200902200302

Nonresponse to tumor necrosis factor antagonists--is there any point in re-treatment?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200902200302

Outcomes after switching from one anti–tumor necrosis factor α agent to a second anti–tumor necrosis factor α agent in patients with rheumatoid arthritis: Results from a large UK national cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200902200302

Switching anti-TNF-alpha agents: what is the evidence?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200902200302

10.1177/039463200902200302

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19822073%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

1 reference